{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:58:59Z","timestamp":1793350739793,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.nano.2017.05.012","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T16:02:11Z","timestamp":1496419331000},"page":"2169-2178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticle-based vaccine formulation stimulates protective immune responses in mice"],"prefix":"10.1016","volume":"13","author":[{"given":"Kai","family":"Schulze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ebensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorne A.","family":"Babiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Gerdts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2017.05.012_bb0005","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1517\/17425247.2014.931936","article-title":"Intranasal formulations: promising strategy to deliver vaccines","volume":"11","author":"Riese","year":"2014","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2017.05.012_bb0010","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.2174\/15680266113136660183","article-title":"Vaccine adjuvants: key tools for innovative vaccine design","volume":"13","author":"Riese","year":"2013","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.nano.2017.05.012_bb0015","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.addr.2003.10.042","article-title":"Poliovirus vaccine strains as mucosal vaccine vectors and their potential use to develop an AIDS vaccine","volume":"56","author":"Crotty","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2017.05.012_bb0020","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.0901466","article-title":"What role does the route of immunization play in the generation of protective immunity against mucosal pathogens?","volume":"183","author":"Belyakov","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2017.05.012_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2016.02.014","article-title":"Mucosal vaccine delivery: Current state and a pediatric perspective","author":"Shakya","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2017.05.012_bb0030","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1517\/14712598.2010.496776","article-title":"Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes","volume":"10","author":"Yu","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.nano.2017.05.012_bb0035","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1051\/vetres:2006014","article-title":"Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa","volume":"37","author":"Cox","year":"2006","journal-title":"Vet Res"},{"key":"10.1016\/j.nano.2017.05.012_bb0040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2515\/therapie:2005030","article-title":"New adjuvants for parenteral and mucosal vaccines","volume":"60","author":"Guy","year":"2005","journal-title":"Therapie"},{"key":"10.1016\/j.nano.2017.05.012_bb0045","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vaccine.2011.11.003","article-title":"New insights in mucosal vaccine development","volume":"30","author":"Pavot","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2017.05.012_bb0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0169-409X(97)00122-1","article-title":"Protein release from polyphosphazene matrices","volume":"31","author":"Payne","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2017.05.012_bb0055","doi-asserted-by":"crossref","first-page":"18936","DOI":"10.1073\/pnas.0908842106","article-title":"Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization","volume":"106","author":"Andrianov","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2017.05.012_bb0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.vetimm.2008.10.298","article-title":"Strategies to link innate and adaptive immunity when designing vaccine adjuvants","volume":"128","author":"Garlapati","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.nano.2017.05.012_bb0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/polym5010161","article-title":"Polyphosphazenes: multifunctional, biodegradable vehicles for drug and gene delivery","volume":"5","author":"Teasdale","year":"2013","journal-title":"Polymers"},{"key":"10.1016\/j.nano.2017.05.012_bb0070","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.1016\/j.vaccine.2011.07.009","article-title":"Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis","volume":"29","author":"Garlapati","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2017.05.012_bb0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7774\/cevr.2015.4.1.23","article-title":"Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes","volume":"4","author":"Powell","year":"2015","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.nano.2017.05.012_bb0080","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3390\/vaccines2030500","article-title":"Caspase-1 dependent IL-1beta secretion and antigen-specific T-cell activation by the novel adjuvant, PCEP","volume":"2","author":"Awate","year":"2014","journal-title":"Vaccines"},{"key":"10.1016\/j.nano.2017.05.012_bb0085","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1016\/j.vaccine.2011.05.026","article-title":"Bis-(3\u2032,5\u2032)-cyclic dimeric adenosine monophosphate: strong Th1\/Th2\/Th17 promoting mucosal adjuvant","volume":"29","author":"Ebensen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2017.05.012_bb0090","doi-asserted-by":"crossref","first-page":"e1005474","DOI":"10.1371\/journal.ppat.1005474","article-title":"Defensins potentiate a neutralizing antibody response to enteric viral infection","volume":"12","author":"Gounder","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.nano.2017.05.012_bb0095","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nchembio.1393","article-title":"Immune modulation by multifaceted cationic host defense (antimicrobial) peptides","volume":"9","author":"Hilchie","year":"2013","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.nano.2017.05.012_bb0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1099\/vir.0.058461-0","article-title":"Induction of mucosal immunity and protection by intranasal immunization with a respiratory syncytial virus subunit vaccine formulation","volume":"95","author":"Garg","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.nano.2017.05.012_bb0105","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.1016\/j.vaccine.2012.06.011","article-title":"Enhanced immune responses and protection by vaccination with respiratory syncytial virus fusion protein formulated with CpG oligodeoxynucleotide and innate defense regulator peptide in polyphosphazene microparticles","volume":"30","author":"Garlapati","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2017.05.012_bb0110","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/14760584.2015.966085","article-title":"Vaccine adjuvant uses of poly-IC and derivatives","volume":"14","author":"Martins","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.nano.2017.05.012_bb0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1586\/14760584.2014.863715","article-title":"Recent progress concerning CpG DNA and its use as a vaccine adjuvant","volume":"13","author":"Shirota","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.nano.2017.05.012_bb0120","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2015.03.017","article-title":"Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination","volume":"206","author":"Mittal","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2017.05.012_bb0125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.nano.2014.08.009","article-title":"Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantation","volume":"11","author":"Mittal","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2017.05.012_bb0130","doi-asserted-by":"crossref","first-page":"e104824","DOI":"10.1371\/journal.pone.0104824","article-title":"Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge","volume":"9","author":"Sanchez","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2017.05.012_bb0135","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1073\/pnas.87.10.3802","article-title":"Introduction of site-specific mutations into the genome of influenza virus","volume":"87","author":"Enami","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2017.05.012_bb0140","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.4049\/jimmunol.167.12.6983","article-title":"The role of antigen in the localization of naive, acutely activated, and memory CD8(+) T cells to the lung during influenza pneumonia","volume":"167","author":"Topham","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2017.05.012_bb0145","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2017.05.012_bb0150","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.vaccine.2011.02.010","article-title":"Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells","volume":"29","author":"Derrick","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2017.05.012_bb0155","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1016\/j.vaccine.2012.05.049","article-title":"Immune markers and correlates of protection for vaccine induced immune responses","volume":"30","author":"Thakur","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2017.05.012_bb0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00281-015-0482-8","article-title":"Effector CD8 T cell immunity in microsporidial infection: a lone defense mechanism","volume":"37","author":"Moretto","year":"2015","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.nano.2017.05.012_bb0165","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","article-title":"Nanoparticle vaccines","volume":"32","author":"Zhao","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2017.05.012_bb0170","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/vaccines3040930","article-title":"From antigen delivery system to adjuvanticy: the board application of nanoparticles in vaccinology","volume":"3","author":"Boraschi","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2017.05.012_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.08.013","article-title":"Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach","volume":"116","author":"des Rieux","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2017.05.012_bb0180","article-title":"Biodegradable polymeric nanoparticles-based vaccine adjuvants for lymph nodes targeting","volume":"4","author":"Gutjahr","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2017.05.012_bb0185","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013006475","article-title":"Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights","volume":"30","author":"Hines","year":"2013","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1016\/j.nano.2017.05.012_bb0190","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.vetimm.2012.01.021","article-title":"Administration of poly[di(sodium carboxylatoethylphenoxy)]phosphazene (PCEP) as adjuvant activated mixed Th1\/Th2 immune responses in pigs","volume":"146","author":"Dar","year":"2012","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.nano.2017.05.012_bb0195","doi-asserted-by":"crossref","first-page":"8306","DOI":"10.1016\/j.vaccine.2010.09.080","article-title":"PCPP (poly[di(carboxylatophenoxy)-phosphazene]) microparticles co-encapsulating ovalbumin and CpG oligo-deoxynucleotides are potent enhancers of antigen specific Th1 immune responses in mice","volume":"28","author":"Garlapati","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2017.05.012_bb0200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1128\/CVI.00250-09","article-title":"Intranasal immunization of mice with a bovine respiratory syncytial virus vaccine induces superior immunity and protection compared to those by subcutaneous delivery or combinations of intranasal and subcutaneous prime-boost strategies","volume":"17","author":"Mapletoft","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.nano.2017.05.012_bb0205","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1016\/j.vaccine.2008.03.031","article-title":"Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen","volume":"26","author":"Mutwiri","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2017.05.012_bb0210","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.vaccine.2009.12.069","article-title":"Efficacy of poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) as mucosal adjuvant to induce protective immunity against respiratory pathogens","volume":"28","author":"Shim","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2017.05.012_bb0215","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/nm1209","article-title":"Vaccines: past, present and future","volume":"11","author":"Plotkin","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.nano.2017.05.012_bb0220","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.vaccine.2006.10.011","article-title":"Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1\/Th2 immune responses in mice immunized with influenza virus antigens","volume":"25","author":"Mutwiri","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2017.05.012_bb0225","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/156720110790396481","article-title":"The potential of polyphosphazenes for delivery of vaccine antigens and immunotherapeutic agents","volume":"7","author":"Eng","year":"2010","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.nano.2017.05.012_bb0230","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-8518-8-4","article-title":"PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens","volume":"8","author":"Eng","year":"2010","journal-title":"J Immune Based Ther Vaccines"},{"key":"10.1016\/j.nano.2017.05.012_bb0235","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1016\/j.vaccine.2011.04.094","article-title":"Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice","volume":"29","author":"Madhun","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2017.05.012_bb0240","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.4049\/jimmunol.1301730","article-title":"Coadministration of polyinosinic:polycytidylic acid and immunostimulatory complexes modifies antigen processing in dendritic cell subsets and enhances HIV gag-specific T cell immunity","volume":"191","author":"Quinn","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2017.05.012_bb0245","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/vaccines2020297","article-title":"Vaccine potentiation by combination adjuvants","volume":"2","author":"Levast","year":"2014","journal-title":"Vaccines"},{"key":"10.1016\/j.nano.2017.05.012_bb0250","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.4049\/jimmunol.1002952","article-title":"Immunization with live and dead chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells","volume":"186","author":"Yu","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2017.05.012_bb0255","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.molimm.2012.03.026","article-title":"Activation of adjuvant core response genes by the novel adjuvant PCEP","volume":"51","author":"Awate","year":"2012","journal-title":"Mol Immunol"},{"key":"10.1016\/j.nano.2017.05.012_bb0260","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.addr.2013.05.013","article-title":"Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant","volume":"65","author":"Hafner","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2017.05.012_bb0265","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00262-011-1156-6","article-title":"CAF05: cationic liposomes that incorporate synthetic cord factor and poly(I:C) induce CTL immunity and reduce tumor burden in mice","volume":"61","author":"Hansen","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.nano.2017.05.012_bb0270","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/vaccines3020293","article-title":"Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and Challenges","volume":"3","author":"Coughlan","year":"2015","journal-title":"Vaccines"},{"key":"10.1016\/j.nano.2017.05.012_bb0275","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/eji.200838336","article-title":"Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication","volume":"38","author":"Ciuffreda","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.nano.2017.05.012_bb0280","doi-asserted-by":"crossref","first-page":"12071","DOI":"10.1128\/JVI.01261-07","article-title":"Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines","volume":"81","author":"Kannanganat","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2017.05.012_bb0285","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1016\/j.vaccine.2013.05.021","article-title":"Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine","volume":"31","author":"Van Braeckel","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2017.05.012_bb0290","doi-asserted-by":"crossref","first-page":"16260","DOI":"10.1073\/pnas.0805325105","article-title":"Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines","volume":"105","author":"Zhu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nano.2017.05.012_bb0295","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1172\/JCI39293","article-title":"Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice","volume":"120","author":"Zhu","year":"2008","journal-title":"J Clin Invest"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963417300989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963417300989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T05:39:10Z","timestamp":1535780350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963417300989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1549963417300989"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2017.05.012","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticle-based vaccine formulation stimulates protective immune responses in mice","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2017.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}